Rosetta Genomics Ltd. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31)

Rosetta Genomics Ltd. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31)

Rosetta Genomics Ltd. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31) of 947.00% as of 2012-12-31, per its 20-F filed 2013-03-22.

Discontinued › Notes › Compensation Related Costs

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1 · last filed 2013-03-22

• 2012-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31) 947.00%.